Skip to main content
Top
Published in: Metabolic Brain Disease 4/2017

01-08-2017 | Original Article

Post 6-OHDA lesion exposure to stress affects neurotrophic factor expression and aggravates motor impairment

Authors: Phumzile Nomfundo Ngema, Musa Vuyisile Mabandla

Published in: Metabolic Brain Disease | Issue 4/2017

Login to get access

Abstract

Chronic exposure to stress amplifies locomotor deficits and exacerbates dopamine neuron loss in an animal model for Parkinson’s disease. The release of neurotrophic factors such as glial cell-line derived neurotrophic factor (GDNF) and neurotrophin-3 (NT-3) following neuronal injury attenuates exacerbated degeneration of these neurons. In this study, the neurotoxin 6-hydroxydopamine (6-OHDA) was injected unilaterally into the medial forebrain bundle of male Sprague Dawley rats. A subset of these rats was subjected to post-lesion restraint stress after which the effect of exposure to stress on locomotor activity (forelimb akinesia test), neurotrophic factor (GDNF and NT-3) and corticosterone concentration was assessed. Exposure to post-lesion stress resulted in increased preference to use the unimpaired forelimb (forelimb ipsilateral to the lesioned hemisphere) in the forelimb akinesia test. The expected increase in both GDNF and NT-3 concentration following injury was not present in the stressed animals. However, both the non-stressed and stressed lesioned groups had decreased neurotrophic factor concentration at one and two weeks post lesion. This decrease was exaggerated in the stressed rats. The decrease in neurotrophic factor concentration was accompanied by an increase in corticosterone concentration in the stressed rats. These findings demonstrate that exposure to post-6-OHDA lesion stress exaggerates dopamine neurodegeneration and enhance motor impairment. This suggests that conditions that result in a hyper-activated hypothalamic-pituitary-adrenal axis such as depression which is concomitant to a Parkinson’s disease diagnosis may be responsible for enhanced dopamine depletion by attenuating neurotrophic factor concentration elevation in the nigrostriatal pathway following neuronal injury.
Literature
go back to reference Allen SJ, Watson JJ, Shoemark DK, Barua NU, Patel NK (2013) GDNF, NGF and BDNF as therapeutic options for neurodegenerations. Pharmacology Therapeutics 138:155–175CrossRefPubMed Allen SJ, Watson JJ, Shoemark DK, Barua NU, Patel NK (2013) GDNF, NGF and BDNF as therapeutic options for neurodegenerations. Pharmacology Therapeutics 138:155–175CrossRefPubMed
go back to reference Andrew R, Watson DG, Best SA, Midgley JM, Wenlong H, Petty RKH (1993) The determination of hydroxydopamines and other trace amines in the urine of parkinsonian patients and normal controls. Neurochem Res 18(11):1175–1177CrossRefPubMed Andrew R, Watson DG, Best SA, Midgley JM, Wenlong H, Petty RKH (1993) The determination of hydroxydopamines and other trace amines in the urine of parkinsonian patients and normal controls. Neurochem Res 18(11):1175–1177CrossRefPubMed
go back to reference Bäck S, Raki M, Tuominen RK, Raasmaja A, Bergström K, Männistö PT (2013) High correlation between in vivo [123I] β-CIT SPECT/CT imaging and post-mortem immunohistochemical findings in the evaluation of lesions induced by 6-OHDA in rats. EJNMMI Res 3:47CrossRef Bäck S, Raki M, Tuominen RK, Raasmaja A, Bergström K, Männistö PT (2013) High correlation between in vivo [123I] β-CIT SPECT/CT imaging and post-mortem immunohistochemical findings in the evaluation of lesions induced by 6-OHDA in rats. EJNMMI Res 3:47CrossRef
go back to reference Bezard E, Dovero S, Prunier C, Ravenscroft P, Chalon S, Guiloteau D, Crossman AR, Bioulac B, Brotchie JM, Gross CE (2001) Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macque model of Parkinson’s disease. J Neurosci 21:6853–6861PubMed Bezard E, Dovero S, Prunier C, Ravenscroft P, Chalon S, Guiloteau D, Crossman AR, Bioulac B, Brotchie JM, Gross CE (2001) Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macque model of Parkinson’s disease. J Neurosci 21:6853–6861PubMed
go back to reference Boix J, Padel T, Paul G (2015) A partial lesion model of Parkinson's disease in mice - characterization of a 6-OHDA-induced medial forebrain bundle lesion. Behav Brain Res 284:196–206CrossRefPubMed Boix J, Padel T, Paul G (2015) A partial lesion model of Parkinson's disease in mice - characterization of a 6-OHDA-induced medial forebrain bundle lesion. Behav Brain Res 284:196–206CrossRefPubMed
go back to reference Breese GR, & Traylor TD (1971). Depletion of brain noradrenaline and dopamine by 6‐hydroxydopamine. Br J Pharmacol 42(1):88–99. Breese GR, & Traylor TD (1971). Depletion of brain noradrenaline and dopamine by 6‐hydroxydopamine. Br J Pharmacol 42(1):88–99.
go back to reference Chen J, Wang ZZ, Zuo W, Zhang S, Chu SF, Chen NH (2016) Effects of chronic mild stress on behavioural and neurobiological parameters—role of glucocorticoid. Horm Behav 78:150–159CrossRefPubMed Chen J, Wang ZZ, Zuo W, Zhang S, Chu SF, Chen NH (2016) Effects of chronic mild stress on behavioural and neurobiological parameters—role of glucocorticoid. Horm Behav 78:150–159CrossRefPubMed
go back to reference Curtius HC, Wolfensberger M, Steinmann B, Redweik U, Siegfried J (1974) Mass fragmentography of dopamine and 6-hydroxydopamine: application to the determination of dopamine in human brain biopsies from the caudate nucleus. J Chromatogr A 99:529–540CrossRef Curtius HC, Wolfensberger M, Steinmann B, Redweik U, Siegfried J (1974) Mass fragmentography of dopamine and 6-hydroxydopamine: application to the determination of dopamine in human brain biopsies from the caudate nucleus. J Chromatogr A 99:529–540CrossRef
go back to reference Dias V, Junn E, Mouradian MM (2013) The role of oxidative stress in Parkinson’s disease. Journal of Parkinson’s Disease 3(4):461–491PubMedPubMedCentral Dias V, Junn E, Mouradian MM (2013) The role of oxidative stress in Parkinson’s disease. Journal of Parkinson’s Disease 3(4):461–491PubMedPubMedCentral
go back to reference Duty S, Jenner P (2011) Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease. Br J Pharmacol 164(4):1357–1391CrossRefPubMedPubMedCentral Duty S, Jenner P (2011) Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease. Br J Pharmacol 164(4):1357–1391CrossRefPubMedPubMedCentral
go back to reference Hemmerle AM, Herman JP, Seroogy KB (2012) Stress, depression and Parkinson's disease. Exp Neurol 233(1):79–86CrossRefPubMed Hemmerle AM, Herman JP, Seroogy KB (2012) Stress, depression and Parkinson's disease. Exp Neurol 233(1):79–86CrossRefPubMed
go back to reference Herrera AJ, Castano A, Venero JL, Cano J, Machado A (2000) The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on dopaminergic system. Neurobiol Dis 7:429–447CrossRefPubMed Herrera AJ, Castano A, Venero JL, Cano J, Machado A (2000) The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on dopaminergic system. Neurobiol Dis 7:429–447CrossRefPubMed
go back to reference Heuer A, Smith GA, Lelos MJ (2012) Unilateral nigrostriatal 6-hydroxydopamine lesions in mice I: motor impairments identify extent of dopamine depletion at three different lesion sites. Behav Brain Res 228:30–43CrossRefPubMed Heuer A, Smith GA, Lelos MJ (2012) Unilateral nigrostriatal 6-hydroxydopamine lesions in mice I: motor impairments identify extent of dopamine depletion at three different lesion sites. Behav Brain Res 228:30–43CrossRefPubMed
go back to reference Hirsch EC, Jenner P, Przedborski SS (2013) Pathogenesis of Parkinson’s disease. Mov Disord. In press Hirsch EC, Jenner P, Przedborski SS (2013) Pathogenesis of Parkinson’s disease. Mov Disord. In press
go back to reference Hwang YP, Kim HG, Han EH, Jeong HG (2008) Metallothionein-III protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in a PI3K and ERK/Nrf2-dependent manner. Toxicol Appl Pharmacol 231(3):318–327CrossRefPubMed Hwang YP, Kim HG, Han EH, Jeong HG (2008) Metallothionein-III protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in a PI3K and ERK/Nrf2-dependent manner. Toxicol Appl Pharmacol 231(3):318–327CrossRefPubMed
go back to reference Jackson-Lewis V, Blesa J, Przedborski S (2012) Animal models of Parkinson's disease. Parkinsonism Related Disorders 18(1):S183–S185CrossRefPubMed Jackson-Lewis V, Blesa J, Przedborski S (2012) Animal models of Parkinson's disease. Parkinsonism Related Disorders 18(1):S183–S185CrossRefPubMed
go back to reference Jing X, Shi H, Zhang C, Ren M, Han M, Wei X, Zhang X, Lou H (2015) Dimethyl fumarate attenuates 6-OHDA-induced neurotoxicity in SH-SY5Y cells and in animal model of Parkinson's disease by enhancing Nrf2 activity. Neuroscience 286:131–140CrossRefPubMed Jing X, Shi H, Zhang C, Ren M, Han M, Wei X, Zhang X, Lou H (2015) Dimethyl fumarate attenuates 6-OHDA-induced neurotoxicity in SH-SY5Y cells and in animal model of Parkinson's disease by enhancing Nrf2 activity. Neuroscience 286:131–140CrossRefPubMed
go back to reference Kim ST, Choi JH, Chang JW, Kim SW, Hwang O (2005) Immobilization stress causes increases in tetrahydrobiopterin, dopamine and neuromelanin an oxidative damage in the nigrostriatal system. J Neurochem 95(1):89–98CrossRefPubMed Kim ST, Choi JH, Chang JW, Kim SW, Hwang O (2005) Immobilization stress causes increases in tetrahydrobiopterin, dopamine and neuromelanin an oxidative damage in the nigrostriatal system. J Neurochem 95(1):89–98CrossRefPubMed
go back to reference Kott JM, Mooney-Leber SM, Shoubah FA, Brummelte S (2016) Effectiveness of different corticosterone administration methods to elevate corticosterone serum levels, induce depressive-like behavior, and affect neurogenesis levels in female rats. Neuroscience 312:201–214CrossRefPubMed Kott JM, Mooney-Leber SM, Shoubah FA, Brummelte S (2016) Effectiveness of different corticosterone administration methods to elevate corticosterone serum levels, induce depressive-like behavior, and affect neurogenesis levels in female rats. Neuroscience 312:201–214CrossRefPubMed
go back to reference Liu SQ (2007) Bioregenerative engineering: principles and applications. John Wiley and Sons, HobokenCrossRef Liu SQ (2007) Bioregenerative engineering: principles and applications. John Wiley and Sons, HobokenCrossRef
go back to reference Lupien SJ, McEwen BS, Gunnar MR, Heim C (2009) Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci 10:434–445CrossRefPubMed Lupien SJ, McEwen BS, Gunnar MR, Heim C (2009) Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci 10:434–445CrossRefPubMed
go back to reference Lv H, Liu J, Wang L, Zhang H, Yu S, Li Z, Jiang F, Niu Y, Yuan J, Cui X, Wang W (2014) Ameliorating effects of combined curcumin and desferrioxamine on 6-OHDA-induced rat mode of Parkinson’s, disease. Cell Biochem Biophys 70(2):1433–1438CrossRefPubMed Lv H, Liu J, Wang L, Zhang H, Yu S, Li Z, Jiang F, Niu Y, Yuan J, Cui X, Wang W (2014) Ameliorating effects of combined curcumin and desferrioxamine on 6-OHDA-induced rat mode of Parkinson’s, disease. Cell Biochem Biophys 70(2):1433–1438CrossRefPubMed
go back to reference Mabandla MV, Russell VA (2010) Voluntary exercise reduces the neurotoxic effects of 6-hydroxydopamine in martenally separated rats. Behavioral brain research 211:16–22CrossRef Mabandla MV, Russell VA (2010) Voluntary exercise reduces the neurotoxic effects of 6-hydroxydopamine in martenally separated rats. Behavioral brain research 211:16–22CrossRef
go back to reference Mattson MP, Lovell MA, Furukawa K, Markesbery WR (1995) Neurotrophic factors attenuate glutamate-induced accumulation of peroxides, elevation of intracellular Ca2+ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons. J Neurochem 65(4):1740–1751CrossRefPubMed Mattson MP, Lovell MA, Furukawa K, Markesbery WR (1995) Neurotrophic factors attenuate glutamate-induced accumulation of peroxides, elevation of intracellular Ca2+ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons. J Neurochem 65(4):1740–1751CrossRefPubMed
go back to reference Patki G, Li L, Allam F, Solanki N, Dao AT, Alkadhi K, Salim S (2014) Moderate treadmill exercise rescues anxiety and depression-like behaviour as well as memory impairment in a rat model of posttraumatic stress disorder. Physiol Behav 130:47–53CrossRefPubMedPubMedCentral Patki G, Li L, Allam F, Solanki N, Dao AT, Alkadhi K, Salim S (2014) Moderate treadmill exercise rescues anxiety and depression-like behaviour as well as memory impairment in a rat model of posttraumatic stress disorder. Physiol Behav 130:47–53CrossRefPubMedPubMedCentral
go back to reference Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd edn. Academic Press, San Diego Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd edn. Academic Press, San Diego
go back to reference Quik M, O’Neill M, Perez XA (2007) Nicotine neuroprotection against nigrostriatal damage: importance of the animal model. Trends Pharmacology Sci 28:229–235CrossRef Quik M, O’Neill M, Perez XA (2007) Nicotine neuroprotection against nigrostriatal damage: importance of the animal model. Trends Pharmacology Sci 28:229–235CrossRef
go back to reference Santiago RM, Barbiero J, Gradowski RW, Bochen S, Lima MM, Da Cunha C, Andreatini R, Vital MA (2014) Induction of depressive-like behavior by intranigral 6-OHDA is directly correlated with deficits in striatal dopamine and hippocampal serotonin. Behav Brain Res 259:70–77CrossRefPubMed Santiago RM, Barbiero J, Gradowski RW, Bochen S, Lima MM, Da Cunha C, Andreatini R, Vital MA (2014) Induction of depressive-like behavior by intranigral 6-OHDA is directly correlated with deficits in striatal dopamine and hippocampal serotonin. Behav Brain Res 259:70–77CrossRefPubMed
go back to reference Schallert, T., & Tillerson, J.L. (2000). Intervention strategies for degeneration of dopamine neurons in Parkinsonism. Optimizing behavioural assessment of outcome. In: Emerich DF, Sandberg PR (Eds) central nervous system diseases: innovative models of CNS diseases from molecule to therapy. Humana, Totowa 131–151. Schallert, T., & Tillerson, J.L. (2000). Intervention strategies for degeneration of dopamine neurons in Parkinsonism. Optimizing behavioural assessment of outcome. In: Emerich DF, Sandberg PR (Eds) central nervous system diseases: innovative models of CNS diseases from molecule to therapy. Humana, Totowa 131–151.
go back to reference Schallert T, Woodlee MT (2005) Motor systems: orienting and placing. In: Whishaw I, Kolb B (eds) The behaviour of the laboratory rat: a handbook with tests. Oxford University Press, New York, pp 129–140 Schallert T, Woodlee MT (2005) Motor systems: orienting and placing. In: Whishaw I, Kolb B (eds) The behaviour of the laboratory rat: a handbook with tests. Oxford University Press, New York, pp 129–140
go back to reference Schapira AH, Jenner P (2011) Etiology and pathogenesis of Parkinson's disease. Movement Disorder 26:1049–1055CrossRef Schapira AH, Jenner P (2011) Etiology and pathogenesis of Parkinson's disease. Movement Disorder 26:1049–1055CrossRef
go back to reference Simola N, Morelli M, Carta AR (2007) The 6-hydroxydopamine model of Parkinson’s disease. Neurotox Res 11(3–4):151–167CrossRefPubMed Simola N, Morelli M, Carta AR (2007) The 6-hydroxydopamine model of Parkinson’s disease. Neurotox Res 11(3–4):151–167CrossRefPubMed
go back to reference Smith AD, Castro SL, Zigmond MJ (2002) Stress-induced Parkinson's disease: a working hypothesis. Physiology and Behaviour 77(4–5):527–531CrossRef Smith AD, Castro SL, Zigmond MJ (2002) Stress-induced Parkinson's disease: a working hypothesis. Physiology and Behaviour 77(4–5):527–531CrossRef
go back to reference Sullivan AM, Toulouse A (2011) Neurotrophic factors for the treatment of Parkinson's disease. Cytokine Growth Factor Rev 22(3):157–165CrossRefPubMed Sullivan AM, Toulouse A (2011) Neurotrophic factors for the treatment of Parkinson's disease. Cytokine Growth Factor Rev 22(3):157–165CrossRefPubMed
go back to reference Tillerson JL, Cohen AD, Philhower J, Miller GW, Zigmond MJ, Schallert T (2001) Forced limb-use effects on the behavioural and neurochemical effects of 6-hydroxydopamine. J Neurosci 21:4427–4435PubMed Tillerson JL, Cohen AD, Philhower J, Miller GW, Zigmond MJ, Schallert T (2001) Forced limb-use effects on the behavioural and neurochemical effects of 6-hydroxydopamine. J Neurosci 21:4427–4435PubMed
go back to reference Toumi ML, Merzoug S, Tahraoui A (2016) Effects of quercetin on predator stress-related hematological and behavioural alterations in pregnant rats and their offspring. J Biosci 41(2):237–249CrossRefPubMed Toumi ML, Merzoug S, Tahraoui A (2016) Effects of quercetin on predator stress-related hematological and behavioural alterations in pregnant rats and their offspring. J Biosci 41(2):237–249CrossRefPubMed
go back to reference Weis J, Saxena S, Evangelopoulo ME, Kruttgen A (2003) Trophic factors in neurodegenerative disorders. Life 55:353–357PubMed Weis J, Saxena S, Evangelopoulo ME, Kruttgen A (2003) Trophic factors in neurodegenerative disorders. Life 55:353–357PubMed
go back to reference Xue YQ, Zhao LR, Guo WP, Duan WM (2007) Intrastriatal administration of erythropoietin protects dopaminergic neurons and improves neurobehavioral outcome in a rat model of Parkinson's disease. Neuroscience 146(3):1245–1258CrossRefPubMed Xue YQ, Zhao LR, Guo WP, Duan WM (2007) Intrastriatal administration of erythropoietin protects dopaminergic neurons and improves neurobehavioral outcome in a rat model of Parkinson's disease. Neuroscience 146(3):1245–1258CrossRefPubMed
go back to reference Zhang W, Hetzel A, Shah B, Atchley D, Blume SR, Padival MA, Rosenkranz JA (2014) Greater physiological and behavioural effects of interrupted stress pattern compared to daily restraint stress in rats. PLoS One 9(7):e102247CrossRefPubMedPubMedCentral Zhang W, Hetzel A, Shah B, Atchley D, Blume SR, Padival MA, Rosenkranz JA (2014) Greater physiological and behavioural effects of interrupted stress pattern compared to daily restraint stress in rats. PLoS One 9(7):e102247CrossRefPubMedPubMedCentral
Metadata
Title
Post 6-OHDA lesion exposure to stress affects neurotrophic factor expression and aggravates motor impairment
Authors
Phumzile Nomfundo Ngema
Musa Vuyisile Mabandla
Publication date
01-08-2017
Publisher
Springer US
Published in
Metabolic Brain Disease / Issue 4/2017
Print ISSN: 0885-7490
Electronic ISSN: 1573-7365
DOI
https://doi.org/10.1007/s11011-017-9988-1

Other articles of this Issue 4/2017

Metabolic Brain Disease 4/2017 Go to the issue